Compare United-Guardian, Inc. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 29.76%
2
The company is Net-Debt Free
3
Flat results in Mar 26
4
With ROE of 18.49%, it has a very attractive valuation with a 2.68 Price to Book Value
5
High Institutional Holdings at 25.89%
6
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
15.59%
0%
15.59%
6 Months
17.48%
0%
17.48%
1 Year
-11.45%
0%
-11.45%
2 Years
-21.42%
0%
-21.42%
3 Years
-14.91%
0%
-14.91%
4 Years
-52.98%
0%
-52.98%
5 Years
-52.38%
0%
-52.38%
United-Guardian, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-0.81%
EBIT Growth (5y)
-9.25%
EBIT to Interest (avg)
3.83
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.75
Sales to Capital Employed (avg)
1.00
Tax Ratio
20.93%
Dividend Payout Ratio
130.92%
Pledged Shares
0
Institutional Holding
25.89%
ROCE (avg)
139.51%
ROE (avg)
29.76%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
2.68
EV to EBIT
9.61
EV to EBITDA
9.17
EV to Capital Employed
8.11
EV to Sales
2.04
PEG Ratio
NA
Dividend Yield
7.62%
ROCE (Latest)
84.39%
ROE (Latest)
18.49%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 7 Schemes (11.01%)
Foreign Institutions
Held by 7 Foreign Institutions (0.71%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
2.90
3.00
-3.33%
Operating Profit (PBDIT) excl Other Income
0.70
0.80
-12.50%
Interest
0.00
0.00
Exceptional Items
0.30
-0.00
Consolidate Net Profit
0.80
0.60
33.33%
Operating Profit Margin (Excl OI)
223.70%
243.70%
-2.00%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -3.33% vs 30.43% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 33.33% vs 100.00% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
10.50
12.20
-13.93%
Operating Profit (PBDIT) excl Other Income
2.40
3.70
-35.14%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
2.10
3.30
-36.36%
Operating Profit Margin (Excl OI)
212.70%
299.40%
-8.67%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -13.93% vs 11.93% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -36.36% vs 26.92% in Dec 2024
About United-Guardian, Inc. 
United-Guardian, Inc.
Specialty Chemicals
United-Guardian, Inc. manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products and specialty industrial products. The Company also conducts research and product development, primarily related to the development of cosmetic and personal care products. Its research and development department also modifies, refines, and expands the uses for existing products. Its products are separated into approximately four distinct product categories, such as personal care products (including cosmetic ingredients), pharmaceuticals, medical products and industrial products. Its personal care products are marketed globally by approximately six marketing partners. The products are sold directly to marketing partners, which in turn resell those products to its customers for use in the manufacture or compounding of the customers' personal care and cosmetic products.
Company Coordinates 
Company Details
230 Marcus Blvd , HAUPPAUGE NY : 11788-3731
Registrar Details






